- Home
- DNLI vs KEN Comparison
DNLI vs KEN Comparison
Compare DNLI & KEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNLI
- KEN
- Stock Information
- Founded
- DNLI 2013
- KEN 2014
- Country
- DNLI United States
- KEN Singapore
- Employees
- DNLI N/A
- KEN N/A
- Industry
- DNLI Biotechnology: Biological Products (No Diagnostic Substances)
- KEN Electric Utilities: Central
- Sector
- DNLI Health Care
- KEN Utilities
- Exchange
- DNLI Nasdaq
- KEN Nasdaq
- Market Cap
- DNLI 1.9B
- KEN 1.7B
- IPO Year
- DNLI 2017
- KEN N/A
- Fundamental
- Price
- DNLI $14.37
- KEN $31.22
- Analyst Decision
- DNLI Strong Buy
- KEN
- Analyst Count
- DNLI 15
- KEN 0
- Target Price
- DNLI $33.92
- KEN N/A
- AVG Volume (30 Days)
- DNLI 1.4M
- KEN 34.5K
- Earning Date
- DNLI 05-06-2025
- KEN 06-02-2025
- Dividend Yield
- DNLI N/A
- KEN 15.37%
- EPS Growth
- DNLI N/A
- KEN N/A
- EPS
- DNLI N/A
- KEN 11.34
- Revenue
- DNLI N/A
- KEN $751,304,000.00
- Revenue This Year
- DNLI N/A
- KEN N/A
- Revenue Next Year
- DNLI $384.25
- KEN N/A
- P/E Ratio
- DNLI N/A
- KEN $2.74
- Revenue Growth
- DNLI N/A
- KEN 8.60
- 52 Week Low
- DNLI $10.57
- KEN $22.84
- 52 Week High
- DNLI $33.33
- KEN $35.49
- Technical
- Relative Strength Index (RSI)
- DNLI 46.97
- KEN 52.43
- Support Level
- DNLI $13.36
- KEN $29.60
- Resistance Level
- DNLI $16.97
- KEN $31.23
- Average True Range (ATR)
- DNLI 0.95
- KEN 0.64
- MACD
- DNLI -0.06
- KEN 0.19
- Stochastic Oscillator
- DNLI 28.08
- KEN 95.08
About DNLI Denali Therapeutics Inc.
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.
About KEN Kenon Holdings Ltd.
Kenon Holdings Ltd is a holding company that operates dynamic, growth-oriented, businesses. The company's operating segments include OPC; CPV Group; and ZIM. It generates maximum revenue from the OPC segment. OPC operates in the Israeli electricity generation sector, including initiating, developing, constructing, and operating power plants and selling and supplying electricity. Geographically, it derives a majority of its revenue from Israel.